Forbes
@forbes·2.1M subscribers·11.3K videos
Moderna Shares Skyrocket 125% Toward Best Day Ever—On Success Of Cancer Drug Trial
Posted
August 19, 2026
Views
2,296
Likes
56
Engagement
2.44%
August 19, 2026
2,296
56
2.44%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
1:43Now PlayingModerna’s stock soared by more than 120% as trading opened Wednesday, more than doubling the biotech giant’s share price after the firm announced positive results from its first-ever late-stage trial of an experimental cancer vaccine.
Read the full story on Forbes
Subscribe to FORBES
Fuel your success with Forbes. Gain unlimited access to premium journalism, including breaking news, groundbreaking in-depth reported stories, daily digests and more. Plus, members get a front-row seat at members-only events with leading thinkers and doers, access to premium video that can help you get ahead, an ad-light experience, early access to select products including NFT drops and more:
Stay Connected
Forbes newsletters
Forbes on Facebook
Forbes Video on Twitter
Forbes Video on Instagram
More From Forbes
Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
